Cached score snapshot
US.DGX · Quest Diagnostics
110分制 55.1/110;5D動能v2 20/50;排序分 75.1/160
Score breakdown
觀望
Score and price trend
Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.
Move the mouse over the chart lines to inspect readings.
- Main score
- 5D momentum v2
- Candlestick
- Historical projection
- Score turn
- Setup grade
| Model | Median | P25/P75 | 歷史相似情境上漲比例 | Down5 | Actual / compare |
|---|---|---|---|---|---|
| Rolling DOE best | -0.32% | -2.37% / +1.52% | 47.5% | 10.8% | Actual -4.20% · vs median -3.88% · inside 25-75 band |
| Historical projection 10D n=160 | +0.26% | -1.82% / +1.87% | 53.8% | 8.1% | Actual -2.00% · vs median -2.26% · inside 25-75 band |
歷史情境統計基於已存檔相似 setup;圖中投影中位線為統計中位數的線性插值展示,並非價格路徑預測或買賣建議。
2026-01-02 → 2026-07-09 · 129 archived points
Summary
score_with_momentum_v2 = main score + 5D momentum v2
Rolling setup rating
Setup quality, historical edge, and risk are combined into a rolling S/A/B/C/D/F grade for this snapshot date.
Score turn monitor
Has the score quality changed?
Run more market refreshes to build enough archived points for a turn check.
Signals
技術信號 18.4 · 資金流 11.6 · 5D動能v2 20
Audit trace
Full calculation detail
Calculation detail · 8 sections
Market inputs
Metrics snapshot
110-point main rating
基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10
基本面 — 3.7/5 · 良好
Sub-items
資金流 — 11.6/20 · 較差
Sub-items
institutional
details
warning
市場環境 — 9/15 · 一般
Sub-items
vix
details
trend
details
qqq
spy
催化劑 — 2/20 · 較差
Sub-items
catalyst
details
風險管理 — 7.4/10 · 良好
Sub-items
position
details
stopLevels
strength_details
diversification
details
技術信號 — 18.4/30 · 一般
Sub-items
vcpPayload
vcp_metrics
情緒分析 — 3/10 · 較差
Sub-items
sentiment
details
sentimentData
Dimension contribution
5D momentum v2 breakdown
Cursor_18.25 5D momentum v2 0-50
Risk management
position
details
stopLevels
strength_details
diversification
details
Calculation audit log
基本面分析總分: 3.7/5分 資金流分析總分: 11.6/20分 市場環境分析總分: 9/15分 催化劑分析: 2/20分 風險管理總分: 7.4/10分 技術信號分析總分: 18.4/30分 情緒分析: 3/10分 共振率(僅顯示不加分): 0%
Technical indicators
adx
atr
cci
cmf
kdj
mfi
obv
rsi
sar
ma50
macd
vwap
volume
derived
ma_cross
bollinger
rsi_short
macd_short
volume_ratio
Raw calculation JSON
{
"risk": {
"level": "Medium",
"reason": "risk management score >= 6.5/10",
"position": {
"score": 1.6,
"details": {
"atrPct": 2.031913204551469,
"turnoverUsdM": 280.0239,
"liquidityPoints": 0.6,
"volatilityPoints": 1
}
},
"rrPoints": 1.4,
"stopLevels": {
"symbol": "US.DGX",
"rr_range": "1:1.0-1:2.5",
"risk_profile": "中等",
"stop_loss_price": 181.2714,
"strength_details": {
"ma_score": 1,
"atr_score": 2,
"rsi_score": 0.5,
"macd_score": 3,
"volume_score": 2
},
"market_adjustment": 1,
"risk_reward_ratio": 1.2,
"stop_loss_percent": 4.1,
"take_profit_price": 198.3975,
"target_multiplier": 1.9,
"technical_strength": 1.75,
"take_profit_percent": 5
},
"positionPoints": 1.6,
"stopLossPoints": 2.4,
"diversification": {
"score": 2,
"details": {
"method": "sector concentration proxy; no portfolio holdings used",
"sector": "Health Care",
"concentratedSectorPenalty": 0
}
},
"riskRewardRatio": 1.2303675149115723,
"stopLossPercent": 4.063826409102938,
"diversificationPoints": 2
},
"total": {
"max": 160,
"result": 75.1,
"formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
"baseScore": 55.1,
"modelVersion": "cursor_18_27_news_v2_160",
"momentum5dScore": 20
},
"market": {
"ma20": 178.6655,
"ma50": 182.0142,
"close": 188.95,
"prevClose": 189.49,
"avgVolume20": 897400,
"volumeRatio": 1.65,
"changePercent": -0.28
},
"sources": {
"catalyst": "finnhub_news_keyword_model",
"sentiment": "finnhub_news_keyword_model",
"fundamentals": "fmp_stable",
"institutional": null,
"marketContext": "twelvedata+fred+database-backfill-market-proxy"
},
"barCount": 145,
"momentum": {
"max": 50,
"result": 20,
"details": {
"ret_5d": 0.07394566329430474,
"max_score": 50,
"max_total": 50,
"raw_total": 20,
"vcp_bonus": 0,
"vol_ratio": 1.6995607747795274,
"ret_points": 12,
"vol_points": 6,
"range_ratio": 1.2744043771689109,
"volat_points": 2,
"day_range_pct": 0.02243983593543261,
"model_version": "cursor_18_27_news_v2_160",
"available_bars": 30,
"breakout_points": 0,
"partial_history": false,
"pullback_points": 0,
"breakout_vol_bonus": 0,
"first_breakout_20d": false,
"return_window_days": 5,
"first_breakout_bonus": 0,
"breakout_quality_points": 0
},
"formula": "Cursor_18.25 5D momentum v2 0-50",
"modelVersion": "cursor_18_27_news_v2_160"
},
"scoreMax": 110,
"composite": {
"max": 160,
"result": 75.1,
"formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
"weights": [
{
"raw": 3.7,
"label": "基本面",
"weight": "5/110",
"normalized": 74,
"contribution": 3.7
},
{
"raw": 11.6,
"label": "資金流",
"weight": "20/110",
"normalized": 58,
"contribution": 11.6
},
{
"raw": 9,
"label": "市場環境",
"weight": "15/110",
"normalized": 60,
"contribution": 9
},
{
"raw": 2,
"label": "催化劑",
"weight": "20/110",
"normalized": 10,
"contribution": 2
},
{
"raw": 7.4,
"label": "風險管理",
"weight": "10/110",
"normalized": 74,
"contribution": 7.4
},
{
"raw": 18.4,
"label": "技術信號",
"weight": "30/110",
"normalized": 61.33,
"contribution": 18.4
},
{
"raw": 3,
"label": "情緒分析",
"weight": "10/110",
"normalized": 30,
"contribution": 3
}
],
"modelVersion": "cursor_18_27_news_v2_160"
},
"momentumMax": 50,
"scoreStatus": "checked",
"standard110": {
"rating": "觀望",
"result": 55.1,
"details": [
"基本面分析總分: 3.7/5分",
"資金流分析總分: 11.6/20分",
"市場環境分析總分: 9/15分",
"催化劑分析: 2/20分",
"風險管理總分: 7.4/10分",
"技術信號分析總分: 18.4/30分",
"情緒分析: 3/10分",
"共振率(僅顯示不加分): 0%"
],
"formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
"dimensionScores": {
"催化劑": 2,
"基本面": 3.7,
"資金流": 11.6,
"市場環境": 9,
"情緒分析": 3,
"技術信號": 18.4,
"風險管理": 7.4
},
"dimensionDetails": {
"催化劑": {
"max": 20,
"grade": "較差",
"items": {
"catalyst": {
"score": 2,
"details": {
"source": "finnhub_news_keyword_model",
"articleCount": 5,
"catalystCount": 0
}
},
"catalystPoints": 2
}
},
"基本面": {
"max": 5,
"grade": "良好",
"items": {
"pbPoints": 0.4,
"pePoints": 0.4,
"epsPoints": 0.4,
"roePoints": 0.4,
"debtPoints": 0.4,
"marginPoints": 0,
"turnoverUsdM": 280.0239,
"volumePoints": 0.5,
"revenuePoints": 0.4,
"dividendPoints": 0.3,
"marketCapPoints": 0.5
},
"source": "fmp_stable"
},
"資金流": {
"max": 20,
"grade": "較差",
"items": {
"cmfPoints": 2.4,
"mfiPoints": 2.4,
"obvPoints": 0.8,
"vwapPoints": 4,
"institutional": {
"score": 2,
"details": {
"source": "optional-neutral",
"warning": {
"code": "INSTITUTIONAL_DATA_OPTIONAL",
"symbol": "US.DGX",
"message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
},
"optional": true,
"holderCount": null,
"holderPoints": 2,
"top10ShareRatio": null,
"concentrationPenalty": 0
}
},
"institutionPoints": 2
}
},
"市場環境": {
"max": 15,
"grade": "一般",
"items": {
"vix": {
"score": 1.8,
"details": {
"source": "twelvedata+fred+database-backfill-market-proxy",
"vixClose": 20.09
}
},
"trend": {
"score": 3.4,
"details": {
"qqq": {
"ma20": 121.98465392607886,
"ma50": 119.41417806680984,
"name": "QQQ",
"close": 120.02993738567542,
"points": 1.4
},
"spy": {
"ma20": 112.53347409917129,
"ma50": 110.23726906087428,
"name": "SPY",
"close": 112.77327192153848,
"points": 2
},
"source": "twelvedata+fred+database-backfill-market-proxy"
}
},
"atrPct": 2.031913204551469,
"atrPoints": 3,
"cciPoints": 0.8,
"vixPoints": 1.8,
"marketTrendPoints": 3.4
}
},
"情緒分析": {
"max": 10,
"grade": "較差",
"items": {
"sentiment": {
"score": 3,
"details": {
"source": "finnhub_news_keyword_model",
"articleCount": 5,
"negativeHits": 0,
"positiveHits": 1,
"sentimentScoreRaw": 0.5
}
},
"sentimentData": {
"raw": [
{
"id": 140615840,
"url": "https://finnhub.io/api/news?id=7a05145bb3efb646e93dac1f0de09e97ba5cca4144e93d6c03b19c31c4663b96",
"image": "https://www.chartmill.com/images/uploads/Best_Dividend_500_264px_webp_9524a3945f.webp",
"source": "ChartMill",
"related": "DGX",
"summary": "Quest Diagnostics (DGX) offers a 1.75% dividend yield with strong 7.42% annual growth. Featuring a sustainable 35% payout ratio and solid profitability, this stock balances reliable income with financial stability.",
"category": "company",
"datetime": 1781255440,
"headline": "Quest Diagnostics Inc (NYSE:DGX): A Top Dividend Stock with Sustainable Income and Growth Potential"
},
{
"id": 140525740,
"url": "https://finnhub.io/api/news?id=b6e2bb6fd8edc2cbeb62be5f1f745e81049b3943c34ac194c362fabb2300bba5",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "DGX",
"summary": "Quest Diagnostics is in focus today as the latest update shows no changes to the current price targets set by covering analysts. Even without fresh commentary driving the story, the lack of adjustment itself can be useful context as you think about how the stock fits into your watchlist or portfolio. Read on to see how to monitor future shifts in the analyst narrative so you can stay on top of what changes and what stays the same. Wall Street's queuing for one rocket. While SpaceX counts down...",
"category": "company",
"datetime": 1780592890,
"headline": "How The Quest Diagnostics (DGX) Investment Story Is Evolving Without New Analyst Price Target Changes"
},
{
"id": 140460566,
"url": "https://finnhub.io/api/news?id=5ee75f7ec4104dac24b2e468a1a398513a80b7f1280003cf01ea79f11012230e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "DGX",
"summary": "Quest Diagnostics (DGX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.",
"category": "company",
"datetime": 1780070404,
"headline": "Quest Diagnostics (DGX) Upgraded to Buy: Here's What You Should Know"
},
{
"id": 140447040,
"url": "https://finnhub.io/api/news?id=76fa090f28882e13396e37f10e3432b5d04a945f44a80319e578848ce3e5f679",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "DGX",
"summary": "Since November 2025, Quest has been in a holding pattern, posting a small return of 2.6% while floating around $194.06. The stock also fell short of the S&P 500’s 9.8% gain during that period.",
"category": "company",
"datetime": 1779989187,
"headline": "3 Reasons to Sell DGX and 1 Stock to Buy Instead"
},
{
"id": 140421419,
"url": "https://finnhub.io/api/news?id=f865a9a57f7dd61d98179f034b0e6aea3ce3f70dd23d597cc203834196aec7f1",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "DGX",
"summary": "Here is how Quest Diagnostics (DGX) and DaVita HealthCare (DVA) have performed compared to their sector so far this year.",
"category": "company",
"datetime": 1779802801,
"headline": "Are Medical Stocks Lagging Quest Diagnostics (DGX) This Year?"
}
],
"raw_source": [
{
"id": 140668871,
"url": "https://finnhub.io/api/news?id=08a165bfc9d22174df2b848db02f7eb78726040bc8f617e12f26030cdc3b4bd5",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "DGX",
"summary": "While Quest Diagnostics has lagged behind the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s prospects.",
"category": "company",
"datetime": 1781838718,
"headline": "Is Quest Diagnostics Stock Underperforming the S&P 500?"
},
{
"id": 140665236,
"url": "https://finnhub.io/api/news?id=10a66dda14b20e65fc5be2ae6f7932dd68373d8b45a9c33eed65c7ea20cc6dbe",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "DGX",
"summary": "Labcorp Holdings has underperformed the Nasdaq over the past year, but analysts are highly optimistic about the stock’s prospects.",
"category": "company",
"datetime": 1781789504,
"headline": "Is Labcorp Holdings Stock Underperforming the Nasdaq?"
},
{
"id": 140662649,
"url": "https://finnhub.io/api/news?id=a3ddc6fc60a25650a6a7b7ec00f1098550bdd259930a161fd2522e1fd6aaeaee",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "DGX",
"summary": "A common bacterial strain that lives naturally in people's guts can cause a dangerous or deadly infection for some, especially when it becomes multidrug-resistant and causes chronic urinary-tract infections (UTIs) in elderly women. But the extent of its effect on the broader population and its prevalence in the community was not well known – until now.",
"category": "company",
"datetime": 1781787420,
"headline": "UTI-causing Bacteria Resistant to Current Drugs, Finds National Study by Hackensack Meridian CDI and Quest Diagnostics"
},
{
"id": 140652802,
"url": "https://finnhub.io/api/news?id=a2d1114a3464516682d5c89b546eb31ebc0c8cf8a5790a0e30e3eaea95e07646",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "DGX",
"summary": "Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced today that it will report its second quarter 2026 financial results on Thursday, July 23, 2026, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.",
"category": "company",
"datetime": 1781701200,
"headline": "Quest Diagnostics to Release Second Quarter Financial Results on July 23, 2026"
},
{
"id": 140645122,
"url": "https://finnhub.io/api/news?id=02545c56786bbb69e32353ee74b7b0c8716b762e706b90b0f64b40239d51d26e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "DGX",
"summary": "Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today unveiled its 2025 Corporate Responsibility Report.",
"category": "company",
"datetime": 1781614800,
"headline": "Quest Diagnostics Unveils Achievements in Healthcare Access, Employee Engagement and Environmental Sustainability in 2025 Corporate Responsibility Report"
},
{
"id": 140645123,
"url": "https://finnhub.io/api/news?id=f6eb967deba60429c3484684beb7ee44db64e94e7fe5eb8e4629bd0c8f289fd2",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "DGX",
"summary": "GAITHERSBURG, Md., June 16, 2026--GeneDx today announced the appointment of Mark Gardner as President, effective June 15, 2026.",
"category": "company",
"datetime": 1781613000,
"headline": "GeneDx Names Mark Gardner President to Lead Its Next Phase of Scale and Growth"
},
{
"id": 140615840,
"url": "https://finnhub.io/api/news?id=7a05145bb3efb646e93dac1f0de09e97ba5cca4144e93d6c03b19c31c4663b96",
"image": "https://www.chartmill.com/images/uploads/Best_Dividend_500_264px_webp_9524a3945f.webp",
"source": "ChartMill",
"related": "DGX",
"summary": "Quest Diagnostics (DGX) offers a 1.75% dividend yield with strong 7.42% annual growth. Featuring a sustainable 35% payout ratio and solid profitability, this stock balances reliable income with financial stability.",
"category": "company",
"datetime": 1781255440,
"headline": "Quest Diagnostics Inc (NYSE:DGX): A Top Dividend Stock with Sustainable Income and Growth Potential"
},
{
"id": 140594190,
"url": "https://finnhub.io/api/news?id=fe13425cb83a2200bec8c0a082ede13f10cef8dcd706a56d10cff8412575574d",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "DGX",
"summary": "Quest Diagnostics, DaVita, LifeStance Health and Aveanna Healthcare are benefiting from telehealth, AI adoption and growing home-care demand.",
"category": "company",
"datetime": 1781097720,
"headline": "Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, LifeStance Health and Aveanna Healthcare"
},
{
"id": 140581606,
"url": "https://finnhub.io/api/news?id=9bb8e271a7af0c14ca05659cc4848cc2352964d67cf4361222aad63995e29041",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "DGX",
"summary": "An aging population and rising telehealth and AI adoption boost demand in the Zacks Medical - Outpatient and Home Healthcare industry. DGX, DVA, LFST and AVAH stand to benefit.",
"category": "company",
"datetime": 1781016000,
"headline": "4 Outpatient Home Health Stocks Benefiting From Industry Trends"
},
{
"id": 140535106,
"url": "https://finnhub.io/api/news?id=c57369c47aa907aaf1780d15a262ad0b4f4f1dab02017c63aa94889e370381aa",
"image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
"source": "ChartMill",
"related": "DGX",
"summary": "Before the US market kicks off on Friday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.",
"category": "company",
"datetime": 1780662900,
"headline": "Top S&P500 movers in Friday's pre-market session"
},
{
"id": 140525740,
"url": "https://finnhub.io/api/news?id=b6e2bb6fd8edc2cbeb62be5f1f745e81049b3943c34ac194c362fabb2300bba5",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "DGX",
"summary": "Quest Diagnostics is in focus today as the latest update shows no changes to the current price targets set by covering analysts. Even without fresh commentary driving the story, the lack of adjustment itself can be useful context as you think about how the stock fits into your watchlist or portfolio. Read on to see how to monitor future shifts in the analyst narrative so you can stay on top of what changes and what stays the same. Wall Street's queuing for one rocket. While SpaceX counts down...",
"category": "company",
"datetime": 1780592890,
"headline": "How The Quest Diagnostics (DGX) Investment Story Is Evolving Without New Analyst Price Target Changes"
},
{
"id": 140525741,
"url": "https://finnhub.io/api/news?id=a1bf00dc6631b26eca5d16cb6f543b49929f4df34a2acc38cb31b2b6ca08fa8b",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "DGX",
"summary": "DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
"category": "company",
"datetime": 1780587012,
"headline": "DaVita HealthCare (DVA) Up 0.6% Since Last Earnings Report: Can It Continue?"
},
{
"id": 140486850,
"url": "https://finnhub.io/api/news?id=9aa04f5b5fbf5aa0c2ffc3af4c508d1720ce92f4d02c51a44b98134b51b03e09",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "DGX",
"summary": "EHC is expanding its rehabilitation network with a new 36-bed hospital in West Virginia.",
"category": "company",
"datetime": 1780315740,
"headline": "Encompass Health to Expand WV Footprint With 36-Bed Bridgeport Unit"
},
{
"id": 140460566,
"url": "https://finnhub.io/api/news?id=5ee75f7ec4104dac24b2e468a1a398513a80b7f1280003cf01ea79f11012230e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "DGX",
"summary": "Quest Diagnostics (DGX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.",
"category": "company",
"datetime": 1780070404,
"headline": "Quest Diagnostics (DGX) Upgraded to Buy: Here's What You Should Know"
},
{
"id": 140447040,
"url": "https://finnhub.io/api/news?id=76fa090f28882e13396e37f10e3432b5d04a945f44a80319e578848ce3e5f679",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "DGX",
"summary": "Since November 2025, Quest has been in a holding pattern, posting a small return of 2.6% while floating around $194.06. The stock also fell short of the S&P 500’s 9.8% gain during that period.",
"category": "company",
"datetime": 1779989187,
"headline": "3 Reasons to Sell DGX and 1 Stock to Buy Instead"
},
{
"id": 140421419,
"url": "https://finnhub.io/api/news?id=f865a9a57f7dd61d98179f034b0e6aea3ce3f70dd23d597cc203834196aec7f1",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "DGX",
"summary": "Here is how Quest Diagnostics (DGX) and DaVita HealthCare (DVA) have performed compared to their sector so far this year.",
"category": "company",
"datetime": 1779802801,
"headline": "Are Medical Stocks Lagging Quest Diagnostics (DGX) This Year?"
},
{
"id": 140413445,
"url": "https://finnhub.io/api/news?id=ae610d13ba08036a4003a9833ecc4cb745d5da2b4a568427191a590b2d4807f0",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "DGX",
"summary": "Quest Diagnostics is keeping analysts reasonably upbeat as steady execution and momentum continue supporting Wall Street confidence.",
"category": "company",
"datetime": 1779712356,
"headline": "Quest Diagnostics Stock: Analyst Estimates & Ratings"
},
{
"id": 140397951,
"url": "https://finnhub.io/api/news?id=714544268cb0481d8b078b9c8724263249e73d28d3824cb2fc661958e6c22ccc",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "DGX",
"summary": "Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.",
"category": "company",
"datetime": 1779542215,
"headline": "1 Profitable Stock to Own for Decades and 2 We Avoid"
}
],
"data_source": "finnhub_news_keyword_model",
"article_count": 5,
"negative_hits": 0,
"positive_hits": 1,
"recomputed_at_score": true,
"sentiment_score_raw": 0.5,
"source_article_count": 18,
"discarded_article_count": 13
},
"sentimentPoints": 3
}
},
"技術信號": {
"max": 30,
"raw": 18.4,
"grade": "一般",
"items": {
"bbPoints": 3,
"adxPoints": 3,
"sarPoints": 2.4000000000000004,
"vcpPoints": 0.9,
"macdPoints": 4,
"vcpPayload": {
"vcp_pass": false,
"vcp_score": 0.9,
"vcp_reason": "站上MA50;升放量(近10日4日);Ready=N;Confirm=N",
"vcp_metrics": {
"up_days": 5,
"vol_ref": 929630,
"down_days": 4,
"vcp_ready": false,
"above_ma50": true,
"avg_vol_10": 1013580,
"avg_vol_20": 871990,
"avg_vol_30": 929630,
"range_pct_10": 0.10484265678750998,
"range_pct_20": 0.10484265678750998,
"range_pct_30": 0.10484265678750998,
"up_expand_ok": true,
"lookback_used": 79,
"near_20d_high": true,
"contraction_ok": false,
"down_shrink_ok": false,
"up_expand_days": 4,
"breakout_20d_ok": false,
"vol_ratio_10_30": 1.090304744898508,
"dist_to_20d_high": 0.01068123929623347,
"down_shrink_days": 2,
"breakout_level_20d": 190.99001,
"vcp_breakout_confirm": false,
"contraction_ratio_10_30": 1
},
"vcp_name_en": "Volatility Contraction Pattern",
"vcp_name_zh": "波動收縮形態",
"vol_contraction": false
},
"kdjAdxPoints": 0.7,
"rsiKdjPoints": 2.4,
"volumeWeight": 2,
"maCrossPoints": 0,
"shortRsiPoints": 0.4,
"shortMacdPoints": 0.4,
"volConfirmPoints": 0,
"volumePointsTechnical": 1.2
}
},
"風險管理": {
"max": 10,
"grade": "良好",
"items": {
"position": {
"score": 1.6,
"details": {
"atrPct": 2.031913204551469,
"turnoverUsdM": 280.0239,
"liquidityPoints": 0.6,
"volatilityPoints": 1
}
},
"rrPoints": 1.4,
"stopLevels": {
"symbol": "US.DGX",
"rr_range": "1:1.0-1:2.5",
"risk_profile": "中等",
"stop_loss_price": 181.2714,
"strength_details": {
"ma_score": 1,
"atr_score": 2,
"rsi_score": 0.5,
"macd_score": 3,
"volume_score": 2
},
"market_adjustment": 1,
"risk_reward_ratio": 1.2,
"stop_loss_percent": 4.1,
"take_profit_price": 198.3975,
"target_multiplier": 1.9,
"technical_strength": 1.75,
"take_profit_percent": 5
},
"positionPoints": 1.6,
"stopLossPoints": 2.4,
"diversification": {
"score": 2,
"details": {
"method": "sector concentration proxy; no portfolio holdings used",
"sector": "Health Care",
"concentratedSectorPenalty": 0
}
},
"riskRewardRatio": 1.2303675149115723,
"stopLossPercent": 4.063826409102938,
"diversificationPoints": 2
}
}
}
},
"modelVersion": "cursor_18_27_news_v2_160",
"providerErrors": [],
"rankingScoreMax": 160,
"dataCompleteness": {
"complete": true,
"missingFields": [],
"optionalInputs": [
"institutionalData"
],
"requiredInputs": [
"fundamentals",
"marketContext.VIX",
"marketContext.SPY",
"marketContext.QQQ",
"catalystData",
"sentimentData",
"ATR",
"sector"
],
"optionalInputWarnings": []
},
"technicalIndicators": {
"adx": 92.86,
"atr": {
"atr": 3.8393,
"rule": "ATR / current price; lower volatility scores higher",
"score": 6,
"atr_pct": 2.03
},
"cci": {
"rule": "Cursor_18.24 CCI bands",
"level": "超買或超賣風險",
"score": 2,
"value": 177.5
},
"cmf": {
"rule": "Cursor_18.24 CMF bands",
"level": "輕微流入",
"score": 6,
"value": 0.1452
},
"kdj": {
"d": 76.98,
"j": 103.35,
"k": 85.77,
"rule": "Cursor_18.24 K/D cross",
"score": 4,
"signal": "金叉"
},
"mfi": {
"rule": "Cursor_18.24 MFI bands",
"level": "平衡",
"score": 6,
"value": 56.25
},
"obv": {
"rule": "Cursor_18.24 recent_slope vs previous_slope",
"score": 2,
"trend": "資金流出",
"value": -5923400,
"recentSlope": -68500,
"previousSlope": -15930
},
"rsi": 70.55,
"sar": {
"rule": "Cursor_18.24 Parabolic SAR",
"score": 8,
"trend": "上升",
"value": 176.6378,
"position": "SAR喺價下",
"distancePct": 6.52,
"previousTrend": "上升"
},
"ma50": 182.0142,
"macd": {
"macd": 1.820366665080769,
"trend": "強烈看漲",
"signal": -0.06379079292106576,
"histogram": 1.8841574580018348
},
"vwap": {
"rule": "Cursor_18.24 VWAP 20D consecutive close",
"score": 10,
"value": 179.7256,
"position": "連續5日>VWAP",
"consecutiveAbove": 5
},
"volume": {
"rule": "Cursor_18.24 volume ratio",
"level": "有量",
"ratio": 1.65,
"score": 6,
"avgVolume": 897400,
"currentVolume": 1482000
},
"derived": {
"ma20": 178.6655,
"ma50": 182.0142,
"prevClose": 189.49,
"avgVolume10": 1086900,
"avgVolume20": 897400,
"changePercent": -0.28,
"avgVolumeForScore": 897400
},
"ma_cross": {
"ma20": 178.6655,
"ma50": 182.0142,
"rule": "Cursor_18.24 MA20/MA50 cross",
"cross": "熊勢",
"score": 0,
"prevMa20": 178.0255,
"prevMa50": 181.8004,
"spreadPct": 1.84,
"isVolumeBreakout": false
},
"bollinger": {
"lower": 167.7908,
"upper": 189.5402,
"position": "上半部"
},
"rsi_short": 92.35,
"macd_short": {
"macd": 0,
"trend": "中性",
"signal": 0,
"histogram": 0
},
"volume_ratio": {
"ratio": 1.65
}
}
}
Raw metrics JSON
{
"close": 188.95,
"volume": 1482000,
"changePercent": -0.28
}
Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.